Laura Oliphant, a director at Aehr Test Systems ($AEHR), sold shares on the open market six times over the last year for a total of $250,252. Her most recent sale occurred on January 22, 2026. These transactions rank 7,963rd out of 11,678 insiders in our database, well below the average sale value of $8.6 million across 6.4 transactions per insider. She made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 22, 2026 | AEHR TEST SYSTEMS | $AEHR | OLIPHANT LAURA | Director | S | Common Stock | 140 | $31.49 | 26,097.0000 | 30,627,342 | 0.53% | 0.00% |
| Jan. 22, 2026 | AEHR TEST SYSTEMS | $AEHR | OLIPHANT LAURA | Director | S | Common Stock | 1026 | $31.44 | 26,517.0000 | 30,627,342 | 3.73% | 0.00% |
| Jan. 22, 2026 | AEHR TEST SYSTEMS | $AEHR | OLIPHANT LAURA | Director | S | Common Stock | 180 | $31.45 | 26,337.0000 | 30,627,342 | 0.68% | 0.00% |
| Jan. 22, 2026 | AEHR TEST SYSTEMS | $AEHR | OLIPHANT LAURA | Director | S | Common Stock | 100 | $31.46 | 26,237.0000 | 30,627,342 | 0.38% | 0.00% |
| Jan. 22, 2026 | AEHR TEST SYSTEMS | $AEHR | OLIPHANT LAURA | Director | S | Common Stock | 3100 | $31.38 | 27,543.0000 | 30,627,342 | 10.12% | 0.01% |
| July 25, 2025 | AEHR TEST SYSTEMS | $AEHR | OLIPHANT LAURA | Director | S | Common Stock | 5000 | $21.50 | 30,643.0000 | 29,915,061 | 14.03% | 0.02% |
| July 2, 2025 | AEHR TEST SYSTEMS | $AEHR | OLIPHANT LAURA | Director | A | Common Stock | 9253 | $0.00 | 35,643.0000 | 0 | 35.06% | 0.00% |
| July 11, 2024 | AEHR TEST SYSTEMS | $AEHR | OLIPHANT LAURA | Director | A | Common Stock | 9265 | $0.00 | 26,390.0000 | 0 | 54.10% | 0.00% |